Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies
暂无分享,去创建一个
K. Awai | K. Chayama | T. Kimura | Y. Nagata | Y. Murakami | M. Kenjo | H. Aikata | I. Nishibuchi | Y. Doi | N. Imano | Y. Takeuchi | I. Takahashi | T. Katsuta
[1] K. Chayama,et al. Long‐term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.
[2] M. Schipper,et al. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. , 2018, International journal of radiation oncology, biology, physics.
[3] L. Dawson,et al. Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. , 2017, Seminars in radiation oncology.
[4] T. Kimura,et al. Dosimetric impact of Lipiodol in stereotactic body radiation therapy on liver after trans‐arterial chemoembolization , 2017, Medical physics.
[5] P. Liang,et al. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm , 2016, BMC Cancer.
[6] E. Kunieda,et al. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation , 2016, Cancer.
[7] J. Bruix,et al. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.
[8] G. Eslick,et al. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. , 2015, JAMA oncology.
[9] K. Awai,et al. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[10] E. Kunieda,et al. Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients , 2014, Acta oncologica.
[11] Hodgkin Lymphoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .
[12] E. Dellon,et al. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , 2014 .
[13] Zahra Kassam,et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Dong Han Lee,et al. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , 2012, Cancer.
[15] M. Makuuchi,et al. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. , 2012, Journal of hepatology.
[16] Cynthia S. Johnson,et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.
[17] H. Jang,et al. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer , 2010, BMC Cancer.
[18] Riccardo Lencioni,et al. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.
[19] Kumi Ozaki,et al. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. , 2007, Journal of vascular and interventional radiology : JVIR.